M. Hanekom

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

Matthias Merker, Camille Blin, Stefano Mona et al. · Nature Genetics · 2015 · 554 citations · Full text

Global Spread, Pulmonary Tuberculosis, Phylogenetics +5

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Martin J. Boeree, Norbert Heinrich, Rob E. Aarnoutse et al. · The Lancet Infectious Diseases · 2016 · 379 citations · Full text

A Recently Evolved Sublineage of the <i>Mycobacterium tuberculosis</i> Beijing Strain Family Is Associated with an Increased Ability to Spread and Cause Disease

M. Hanekom, Gian van der Spuy, Elizabeth M. Streicher et al. · Journal of Clinical Microbiology · 2007 · 210 citations · Full text

Molecular Epidemiology, Comparative Genomics, Tuberculosis Prevention +24

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

Andreas H. Diacon, Rodney Dawson, M. Hanekom et al. · The International Journal of Tuberculosis and Lung Disease · 2011 · 203 citations

Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients

Andreas H. Diacon, Rodney Dawson, M. Hanekom et al. · Antimicrobial Agents and Chemotherapy · 2010 · 175 citations · Full text

Tuberculosis Prevention, Bactericidal Activity, Pharmacotherapy +19